Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5602831 | 0.89 | TSHR (0.33) | TSHRTHRB | |
| SCHEMBL5600570 | 0.87 | TSHR (0.32) | TSHR | |
| SCHEMBL6271171 | 0.81 | SMPD1 (0.35) | TSHRTHRBLMNAL3MBTL1 | |
| SCHEMBL2521683 | 0.81 | CYP3A4 (0.34) | TSHRL3MBTL1 | |
| SCHEMBL2518078 | 0.81 | MEN1 (0.37) | THRBLMNAL3MBTL1MEN1CYP1A2 | |
| SCHEMBL2048208 | 0.81 | SMPD1 (0.48) | THRBLMNAL3MBTL1MEN1CYP1A2 | |
| SCHEMBL6268013 | 0.78 | SMPD1 (0.46) | TSHRL3MBTL1MEN1CYP1A2KMT2A | |
| SCHEMBL2049376 | 0.78 | CYP3A4 (0.46) | TSHRL3MBTL1 | |
| SCHEMBL2523115 | 0.77 | TSHR (0.33) | TSHRL3MBTL1 | |
| SCHEMBL6266756 | 0.76 | LPAR3 (0.40) | L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2337805-B2 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | MITSUI CHEMICALS INC (JP) | 2025-06-18 | — | — | EP | disclosed |
| EP-3129353-B1 | METHOD FOR MANUFACTURING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | COVESTRO DEUTSCHLAND AG (DE) | 2024-02-28 | — | — | EP | disclosed |
| WO-2023106258-A1 | POLYMERIZABLE COMPOSITION FOR MANUFACTURING MOLDED ARTICLE, MOLDED ARTICLE AND MANUFACTURING METHOD THEREOF | MITSUI CHEMICALS, INC. (JP) | 2023-06-15 | — | — | WO | disclosed |
| CN-106414538-B | Composition for producing transparent polythiourethane bodies | 科思创德国股份有限公司 | 2020-02-28 | — | — | CN | disclosed |
| US-10294198-B2 | Method for producing xylylene diisocyanates in the gaseous phase | COVESTRO DEUTSCHLAND AG (DE) | 2019-05-21 | — | — | US | disclosed |
| US-10252988-B2 | Composition for producing transparent polythiourethane bodies | COVESTRO DEUTSCHLAND AG (DE) | 2019-04-09 | — | — | US | disclosed |
| US-20170210702-A1 | METHOD FOR PRODUCING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | COVESTRO DEUTSCHLAND AG (DE) | 2017-07-27 | — | — | US | disclosed |
| US-20170121449-A1 | COMPOSITION FOR PRODUCING TRANSPARENT POLYTHIOURETHANE BODIES | MITSUI CHEMICALS, INC. (JP) | 2017-05-04 | — | — | US | disclosed |
| US-20170029552-A1 | COMPOSITION CONTAINING AROMATIC NITRILES FOR THE PRODUCTION OF TRANSPARENT POLYTHIOURETHANE BODIES | COVESTRO DEUTSCHLAND AG (DE) | 2017-02-02 | — | — | US | disclosed |
| EP-2337805-B1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2014-12-17 | — | — | EP | disclosed |
| US-8829147-B2 | Polymerizable liquid composition and process for the production of organic glass starting from polymerizable liquid compositions of the polyurethane type | ACOMON AG (CH) | 2014-09-09 | — | — | US | disclosed |
| US-20110251301-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2011-10-13 | — | — | US | disclosed |
| EP-2337805-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2011-06-29 | — | — | EP | disclosed |
| WO-2010043392-A1 | POLYMERIZABLE LIQUID COMPOSITION AND PROCESS FOR THE PRODUCTION OF ORGANIC GLASS STARTING FROM POLYMERIZABLE LIQUID COMPOSITIONS OF THE POLYURETHANE TYPE | ACOMON AG (CH) | 2010-04-22 | — | — | WO | disclosed |
| EP-1157055-B1 | THERMOSETTING POLY URETHANE/UREA-FORMING COMPOSITIONS | CROMPTON CORP (US) | 2005-12-14 | — | — | EP | disclosed |
| US-6369156-B1 | CURABLE MIXTURE; AROMATIC POLYAMINE CONTAINING THIOETHER GROUP, PHOSPHATE ESTER, AND ALDEHYDE OR ALDEHYDE-FORMING COMPOUND; DISCOLORATION INHIBITION | VANTICO INC. | 2002-04-09 | — | — | US | disclosed |
| EP-1157055-A1 | THERMOSETTING POLY URETHANE/UREA-FORMING COMPOSITIONS | Vantico AG (CH) | 2001-11-28 | — | — | EP | disclosed |
| EP-1097952-A1 | Polurethane/Polyurea-forming compositions | Vantico AG (CH) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000035983-A1 | THERMOSETTING POLY URETHANE/UREA-FORMING COMPOSITIONS | VANTICO AG (CH) | 2000-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10252988-B2 | Composition for producing transparent polythiourethane bodies | PHOSPHO1, PCTP, AGPAT5 | TSHR 2486/4885THRB 2803/4885LMNA 2055/4885 |
| US-10294198-B2 | Method for producing xylylene diisocyanates in the gaseous phase | DCXR, DAD1, PAG1 | TSHR 4447/4885THRB 4801/4885LMNA 2428/4885 |
| US-20170210702-A1 | METHOD FOR PRODUCING XYLYLENE DIISOCYANATES IN THE GASEOUS PHASE | DCXR, DAD1, PAG1 | TSHR 4447/4885THRB 4801/4885LMNA 2428/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.